To Treat or Not to Treat: That Is the Question for Serum

摘要

As regulations on serum importation stagnate, the industry moves toward treatment optionsFetal bovine serum (FBS) is a small-time product of agriculture with a big-time value to biotechnology. About 500,000 liters of FBS are traded worldwide annually with a value in excess of 100 million dollar. The sales of biopharma-ceutical products thatuse FBS as a raw material is in excess of 2 billion dollar and includes mammalian cell products such as human growth hormone, inter-feron, and erythropoetin.